Bicycle Therapeutics
14.46
-0.35 (-2.36%)
At close: Jan 15, 2025, 12:02 PM

Cashflow (Annual)

Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
Year FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16
Net Income -180.66M -112.72M -66.82M -51.01M -30.61M -21.85M -16.26M -13.51M
Depreciation & Amortization 6.55M 3.69M 1.41M 1.28M 960.00K 712.00K 332.00K 269.29K
Stock-Based Compensation 32.48M 26.78M 12.08M 6.51M 3.08M 1.02M 515.00K 123.00K
Other Working Capital 66.45M -248.00K 37.12M 24.00M -10.00M -3.95M 12.96M 1.37M
Other Non-Cash Items 734.03K 442.00K 2.14M 751.00K 5.38M 665.00K 856.00K 182.52K
Deferred Income Tax 3.32M -4.98M -1.67M -673.00K n/a n/a 119.00K n/a
Change in Working Capital 76.96M 672.00K 38.06M 25.35M -7.43M -6.63M 13.02M 1.85M
Operating Cash Flow -60.63M -86.11M -14.79M -17.79M -28.61M -26.08M -1.42M -11.27M
Capital Expenditures -2.93M -18.99M -2.03M -1.20M -1.55M -1.19M -1.11M -243.36K
Acquisitions n/a n/a n/a n/a n/a n/a n/a n/a
Purchase of Investments n/a n/a n/a n/a n/a n/a n/a n/a
Sales Maturities Of Investments n/a n/a n/a n/a n/a n/a n/a n/a
Other Investing Acitivies n/a n/a n/a n/a n/a n/a n/a n/a
Investing Cash Flow -2.93M -18.99M -2.03M -1.20M -1.55M -1.19M -1.11M -243.36K
Debt Repayment n/a n/a 15.00M 15.00M n/a n/a n/a n/a
Common Stock Repurchased n/a n/a n/a n/a n/a -576.00K n/a n/a
Dividend Paid n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies 682.00K 989.00K 7.18M -301.00K 1.48M 26.01M 57.88M 16.77M
Financial Cash Flow 250.03M 6.69M 320.73M 62.84M 58.44M 25.43M 57.88M 16.77M
Net Cash Flow 187.82M -99.53M 302.69M 43.87M 28.74M -4.28M 58.26M 3.46M
Free Cash Flow -63.56M -105.10M -16.82M -18.99M -30.17M -27.26M -2.53M -11.51M

Create Price Alert on BCYC

Your price alert will notify you when the stock price is above 14.46.

Add to Watchlist